Cargando…
NS3 Resistance-Associated Variants (RAVs) in Patients Infected with HCV Genotype 1a in Spain
BACKGROUND: Resistance-associated variants have been related to treatment failure of hepatitis C virus (HCV) therapy with direct-acting antiviral drugs. The aim of our study was to analyze the prevalence of clinically relevant resistance-associated variants within NS3 in patients infected with HCV g...
Autores principales: | Jimenez-Sousa, María Ángeles, Gutiérrez-Rivas, Mónica, Álvaro-Meca, Alejandro, García-Álvarez, Mónica, Harrigan, P. Richard, Fedele, Cesare Giovanni, Briz, Verónica, Vázquez-Morón, Sonia, Resino, Salvador |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042525/ https://www.ncbi.nlm.nih.gov/pubmed/27685471 http://dx.doi.org/10.1371/journal.pone.0163197 |
Ejemplares similares
-
Low frequency of NS5A relevant resistance-associated substitutions to Elbasvir among hepatitis C virus genotype 1a in Spain: a cross-sectional study
por: Palladino, Claudia, et al.
Publicado: (2017) -
Epidemiological Trend of Sepsis in Patients with Hospital Admissions Related to Hepatitis C in Spain (2000–2015): A Nationwide Study
por: Alvaro-Meca, Alejandro, et al.
Publicado: (2020) -
Stroke in HIV-infected individuals with and without HCV coinfection in Spain in the combination antiretroviral therapy era
por: Alvaro-Meca, Alejandro, et al.
Publicado: (2017) -
Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012–2014)
por: Vázquez-Morón, Sonia, et al.
Publicado: (2019) -
Epidemic history and baseline resistance to NS5A-specific direct acting drugs of hepatitis C virus in Spain
por: Palladino, Claudia, et al.
Publicado: (2020)